[ Price : $8.95]
Xenon Pharmaceuticals says its experimental epilepsy drug azetukalner met the primary endpoint in a late-stage clinical trial in p...[ Price : $8.95]
FDA posts an updated draft guidance outlining new and revised recommendations for companies developing biosimilar products.[ Price : $8.95]
FDA sends Incyte a complete response letter for its supplemental BLA for Zynyz (retifanlimab-dlwr) injection that cited inspectio...[ Price : $8.95]
Consumer advocacy group Public Citizen urges Pfizer to commit to maintaining access to its medicines in Europe after comments by C...[ Price : $8.95]
Roche reports that its investigational breast cancer drug giredestrant failed to significantly extend progression-free survival in...[ Price : $8.95]
FDA says it recently held a meeting with several states to discuss implementation of a program that would allow the importation of...[ Price : $8.95]
Ipsen voluntarily withdraws Tazverik (tazemetostat) from the market based on emerging data from the ongoing Phase 1b/3 SYMPHONY-1 ...[ Price : $8.95]
FDA investigators cite manufacturing and documentation issues at an Indian sterile drug facility operated by Maiva Pharma Private ...